Old Ayala, Inc
AYLADelisted Jan 19, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001797336
Old Ayala, Inc was delisted on Jan 19, 2023; its insiders filed their last Form 4 on Jan 24, 2023; 11 institutions reported holding it in 13F filings for Q4 2022, worth $946.5K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Old Ayala, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Old Ayala, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| aMoon Growth Fund Limited Partnership | 10% Owner | 0 | Jan 24, 2023 | 0 |
| Schindel Yair Chaim | Other: shareholder of 10% holder | 0 | Jan 24, 2023 | 0 |
| Goldberg Murray A | Director | – | Jan 23, 2023 | 0 |
| Sidransky David | Director | 0Indirect | Jan 23, 2023 | 0 |
| Maimon Yossi | CFO, Secretary and Treasurer | 0 | Jan 23, 2023 | 0 |
| Spiegel Robert J. | Director | – | Jan 23, 2023 | 0 |
| Mamluk Roni | President & CEO | 0 | Jan 23, 2023 | 0 |
| Gordon Gary B. | Chief Medical Officer | 0 | Jan 23, 2023 | 0 |
| Bisker-Leib Vered | Director | – | Jan 23, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.